5DumortierJ, Chapuisf, Borson 0,et al. Unresectable hepa-tocellular Carcinoma : Survival and prognostic fators after li-piodol chemoembolisation in 89 patients[J]. Dig Liver Dis,2006,38(2):125-133.
6RayK. Liver cancer: The promise of new approaches in themanagement of hepatocellular carcinoma - adding to thetoolbox? [J]. Nature Reviews Gastroenterology and Hepa-tology,2013,10(4) :195-195.
7HoCM, Lee PH,Shau WY,et al. Survival in patients withrecurrent hepatocellular carcinoma after primary hepatecto-my: Comparative effectiveness of treatment modalities〔J].Surgery 2012,151(5) :700-709.
8ChiuJ,Tang YF, Yao TJ , et al. The use of single - agentsorafenib in the treatment of advanced hepatocellular carci-noma patients with underlying Child - Pugh B liver cirrho-sis[J]. Cancer,2012,118(21) . 5293-5301.
9LiuYS,Chuang MT,Tsai YS,et al. Nitroglycerine use intranscatheter arterial (chemo) embolization in patients withhepatocellular carcinoma and dual - energy CT assessmentof Lipiodol retention[J], European radiology, 2012 ,22(10):2193-2200.
10Mikelsaar AV, Sunter A, Mikesaar R, et al. Epitope of titin A-band-specific monoclonal antibody Titl 5 HI.1 is highly conserved in several Fn3 domains of the titin molecule. Centriole staining in human, mouse and zebrafish cells. Cell Div, 2012, 7(1): 21.
